Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc sulfate plus hydroxyzine vs hydroxyzine alone for malnutrition in hemodialysis
IRCT2017102136703N2Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc and hydroxyzine in end-stage kidney disease (ESKD) and protein-calorie malnutrition (PCM) (2 arms), sponsored by Shahroud University of Medical Sciences. Started Nov 2017; status: completed.
02
Drugs
zinchydroxyzine
03
Conditions
end-stage kidney disease (ESKD)protein-calorie malnutrition (PCM)
Beyond the preview
Go deeper on IRCT2017102136703N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017102136703N2.